Left anterior descending (LAD) coronary artery location is reported to be associated with increased propensity to restenosis after intervention. This study, in 3736 patients, investigates whether this finding is equally applicable to intervention with balloon angioplasty (BA, n = 3797 lesions), directional atherectomy (DCA, n = 200 lesions), Palmaz-Schatz stent implantation (PS, n~229 lesions) and excimer laser angioplasty (ELCA, n = 116 lesions). Automated core laboratory quantitative analysis (OCA) was performed in multiple matched angiographic projections pre and post intervention and at 6 month follow up (overall QCA follow up 93%). Multiple linear regression analysis was employed to determine whether LAD lesion location was associated with greater propensity to luminal renarrowing, independently of lesion severity pre, procedural luminal increase and reference vessel diameter. Because of the large variation in vessel size, lumen renarrowing was measured as relative luminal loss (minimal luminal diameter (MLD) post-follow up/reference diameter pre) and angiographic outcome as relative lumen at follow up (MLD at follow up/reference diameter pre). In multivariate analysis applied to the entire patient population, LAD location was independently associated with greater relative loss and smaller lumen at follow up (p = 0.007). However, application of the model to each patient group separately, revealed analogous findings for the DCA (p = 0.003) and BA (p = 0.03) groups, but no significant association between LAD location and late angiographic results was evident in the PS (p = 0.18) or ELCA (p = 0.55) groups. Retrospective exclusion of totally occluded lesions at baseline and/or at follow up from the analysis did not appreciable alter these findings.
Left anterior descending (LAD) coronary artery location is reported to be associated with increased propensity to restenosis after intervention. This study, in 3736 patients, investigates whether this finding is equally applicable to intervention with balloon angioplasty (BA, n = 3797 lesions), directional atherectomy (DCA, n = 200 lesions), Palmaz-Schatz stent implantation (PS, n~229 lesions) and excimer laser angioplasty (ELCA, n = 116 lesions). Automated core laboratory quantitative analysis (OCA) was performed in multiple matched angiographic projections pre and post intervention and at 6 month follow up (overall QCA follow up 93%). Multiple linear regression analysis was employed to determine whether LAD lesion location was associated with greater propensity to luminal renarrowing, independently of lesion severity pre, procedural luminal increase and reference vessel diameter. Because of the large variation in vessel size, lumen renarrowing was measured as relative luminal loss (minimal luminal diameter (MLD) post-follow up/reference diameter pre) and angiographic outcome as relative lumen at follow up (MLD at follow up/reference diameter pre). In multivariate analysis applied to the entire patient population, LAD location was independently associated with greater relative loss and smaller lumen at follow up (p = 0.007). However, application of the model to each patient group separately, revealed analogous findings for the DCA (p = 0.003) and BA (p = 0.03) groups, but no significant association between LAD location and late angiographic results was evident in the PS (p = 0.18) or ELCA (p = 0.55) groups. Retrospective exclusion of totally occluded lesions at baseline and/or at follow up from the analysis did not appreciable alter these findings.
Conclusion: LAD lesions were independently associated with less favourable late angiographic results after balloon angioplasty or directional atherectomy, whereas late results after Palmaz-Schatz stent implantation or excimer laser angioplasty did not vary with lesion location. In contrast with previous reports, these findings suggest a differential influence of lesion location on late interventional results, depending on the device used. Accordinglyfurther investigation will be required for clarification of this association.
(OR = 2.31, P < 0.05) failure. Although no ELCA effect was noted for late clinical outcome (p = 0.56), a trend toward more ELCA-related events was seen in TLR (RR = 1.43; P = 0.06). In conclusion: In lesion subsets suitable for treatment with either device, ELCA-treated patients had: 1) lower Proc-S: 2) more acute complications; and 3) a trend toward more frequent TLR than RA-treated patients. We report on the longterm clinical and angiographic outcome of this subgroup. Procedural success (PS) was defined as <50% residual stenosis at the end of the procedure. Clinical endpoints were: death (D), myocardial infarction (MI), coronary bypass surgery (CABG) or repeat angioplasty (re-PTCA) of the randomized segment within 6 months follow-up. Angiographic endpoint was the net gain (NG) in minimal lumen diameter at six months follow-up relative to the pre-procedural baseline determined by a computer-assisted automated edge detection algorithm (CAAS II). Functional status (FS) at six months was graded according to the Canadian Cardiovascular Society classification.
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Results: Baseline patient characteristics were similar in both groups. ELCA was followed by BA in all patients. Re-occlusion of the treated segment during 6 months follow-up was 33% in the ELCA group versus 23% in the BA group (not significant). Rotational atherectomy (RA) and excimer laser angioplasty (ELCA) are commonly used in lesions unsuitable for balloon angioplasty, but few comparative outcome studies have been performed using these devices in matched subsets. To address this issue, we reviewed the clinical course of 696 patients undergoing RA or ELCA in lesions suitable for either technique. Vein grafts, long (e::20 mm), heavily calcified, thrombus-containing lesions, and total occlusions were excluded. Angiographic «50% final stenosis), procedural (proc-S) «50% stenosis and no in-hospital complications [death, Q-wave myocardial infarction QWMI or CABGI and clinical (Proc-S without rePTCA <14 days) success, and late events (death, QWMI, target lesion revascularization [TLR, CABG or repeat PTCA)) were recorded for 12 months after the procedure. Multivariate logistic regression analysis was performed to evaluate the ELCA effect, accounting for disparities in clinical (unstable angina, diabetes, multivessel disease) and angiographic (AHA/ACC classification, restenosis, length, calcium, eccentricity, angulation, irregularity, and pre-%DS) variables. ELCA remained an independent predictor for angiographic (OR'" 3.72, P < 0.0051, procedural (OR = 2.96, P < 0.01), and clinical
1782-31

